These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 36495700)

  • 21. Modelling direct and herd protection effects of vaccination against the SARS-CoV-2 Delta variant in Australia.
    McBryde ES; Meehan MT; Caldwell JM; Adekunle AI; Ogunlade ST; Kuddus MA; Ragonnet R; Jayasundara P; Trauer JM; Cope RC
    Med J Aust; 2021 Nov; 215(9):427-432. PubMed ID: 34477236
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Best Practices for COVID-19 Mass Vaccination Clinics.
    Shakory S; Eissa A; Kiran T; Pinto AD
    Ann Fam Med; 2022; 20(2):149-156. PubMed ID: 35346931
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Location, location, location: a discrete choice experiment to inform COVID-19 vaccination programme delivery in the UK.
    McPhedran R; Gold N; Bemand C; Weston D; Rosen R; Scott R; Chadborn T; Amlôt R; Mawby M; Toombs B
    BMC Public Health; 2022 Mar; 22(1):431. PubMed ID: 35246082
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Italy's rollout of COVID-19 vaccinations: The crucial contribution of the first experimental mass vaccination site in Lombardy.
    Oliani F; Savoia A; Gallo G; Tiwana N; Letzgus M; Gentiloni F; Piatti A; Chiappa L; Bisesti A; Laquintana D; Castaldi S
    Vaccine; 2022 Mar; 40(10):1397-1403. PubMed ID: 35144846
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Understanding COVID-19 vaccine acceptance in Pakistan: an echo of previous immunizations or prospect of change?
    Ahmed TF; Ahmed A; Ahmed S; Ahmed HU
    Expert Rev Vaccines; 2021 Sep; 20(9):1185-1193. PubMed ID: 34348062
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effects of the COVID-19 pandemic on the use of the performance-enhancing drugs.
    Negro F; Di Trana A; Marinelli S
    Acta Biomed; 2022 Jan; 92(6):e2021401. PubMed ID: 35075058
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Optimizing planning and design of COVID-19 drive-through mass vaccination clinics by simulation.
    Asgary A; Najafabadi MM; Wendel SK; Resnick-Ault D; Zane RD; Wu J
    Health Technol (Berl); 2021; 11(6):1359-1368. PubMed ID: 34631358
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Equitable and Feasible Distribution of SARS-CoV-2 Vaccines for All in Africa.
    Rogers AB; Barrie MB; Fallah MP; Kelly JD
    Am J Trop Med Hyg; 2021 Jun; 105(2):278-280. PubMed ID: 34181573
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Public Perception of COVID-19 Vaccination in Italy: The Role of Trust and Experts' Communication.
    Bucchi M; Fattorini E; Saracino B
    Int J Public Health; 2022; 67():1604222. PubMed ID: 35370537
    [No Abstract]   [Full Text] [Related]  

  • 30. Update on COVID-19 and Effectiveness of a Vaccination Campaign in a Global Context.
    Charitos IA; Ballini A; Lovero R; Castellaneta F; Colella M; Scacco S; Cantore S; Arrigoni R; Mastrangelo F; Dioguardi M
    Int J Environ Res Public Health; 2022 Aug; 19(17):. PubMed ID: 36078427
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Considerations for fair prioritization of COVID-19 vaccine and its mandate among healthcare personnel.
    Hughes K; Gogineni V; Lewis C; Deshpande A
    Curr Med Res Opin; 2021 Jun; 37(6):907-909. PubMed ID: 33760673
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Potential for elimination of SAR-CoV-2 through vaccination as inspired by elimination of multiple influenza viruses through natural pandemics or mass vaccination.
    Chen JM; Sun YX; Chen JW
    J Med Virol; 2020 Nov; 92(11):2453-2457. PubMed ID: 32525587
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Randomized COVID-19 vaccination rollout can offer direct real-world evidence.
    Hemkens LG; Goodman SN
    J Clin Epidemiol; 2021 Oct; 138():199-202. PubMed ID: 34048910
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Operations management on the front line of COVID-19 vaccination: building capability at scale via technology-enhanced learning.
    Smith IM; Bayliss E; Salisbury H; Wheeler A
    BMJ Open Qual; 2021 Jul; 10(3):. PubMed ID: 34244176
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sisonke phase 3B open-label study: Lessons learnt for national and global vaccination scale-up during epidemics.
    Goga AE; Bekker LG; Garrett N; Takuva S; Sanne I; Odhiambo J; Mayat F; Fairall L; Brey Z; Bamford L; Tanna G; Grey G
    S Afr Med J; 2021 Dec; 112(2b):13486. PubMed ID: 35140006
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Global landscape of COVID-19 vaccination progress: insight from an exploratory data analysis.
    Dey SK; Rahman MM; Siddiqi UR; Howlader A; Tushar MA; Qazi A
    Hum Vaccin Immunother; 2022 Dec; 18(1):2025009. PubMed ID: 35050838
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High COVID-19 transmission rates jeopardize global mass vaccination campaigns.
    Zuin M; Zuliani G; Roncon L
    Pathog Glob Health; 2021 Jun; 115(4):213-214. PubMed ID: 33634748
    [No Abstract]   [Full Text] [Related]  

  • 38. COVID-19 Cases and Hospitalizations by COVID-19 Vaccination Status and Previous COVID-19 Diagnosis - California and New York, May-November 2021.
    León TM; Dorabawila V; Nelson L; Lutterloh E; Bauer UE; Backenson B; Bassett MT; Henry H; Bregman B; Midgley CM; Myers JF; Plumb ID; Reese HE; Zhao R; Briggs-Hagen M; Hoefer D; Watt JP; Silk BJ; Jain S; Rosenberg ES
    MMWR Morb Mortal Wkly Rep; 2022 Jan; 71(4):125-131. PubMed ID: 35085222
    [TBL] [Abstract][Full Text] [Related]  

  • 39. First SARS-CoV-2 vaccine booster and influenza vaccination: risk assessment of COVID-19 hospitalisation and death.
    Russo AG; Faccini M; Decarli A; Cattaneo S; Tunesi S; Murtas R; Fagandini F; Bergamaschi W
    Epidemiol Prev; 2022; 46(5-6):324-332. PubMed ID: 36341584
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Covid-19 vaccine management (Comirnaty and mrna-1273 Moderna) in a teaching hospital in Italy: a short report on the vaccination campaign.
    Papini F; Grassi N; Guglielmi G; Gattini V; Rago L; Bisordi C; Scateni M; Totaro M; Tulipani A; Porretta A; Tavoschi L; Guercini J; Luchini G; Briani S; Privitera GP; Baggiani A
    Environ Health Prev Med; 2021 Sep; 26(1):99. PubMed ID: 34592930
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.